Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Drugs that modulate serotonin (5-HT) synaptic concentrations impact neurogenesis and hippocampal (HPC)-dependent learning. The primary objective is to determine the extent to which psilocybin (PSOP) modulates neurogenesis and thereby affects acquisition and extinction of HPC-dependent trace fear conditioning. PSOP, the 5-HT2A agonist 25I-NBMeO and the 5-HT2A/C antagonist ketanserin were administered via an acute intraperitoneal injection to mice. Trace fear conditioning was measured as the amount of time spent immobile in the presence of the conditioned stimulus (CS, auditory tone), trace (silent interval) and post-trace interval over 10 trials. Extinction was determined by the number of trials required to resume mobility during CS, trace and post-trace when the shock was not delivered. Neurogenesis was determined by unbiased counts of cells in the dentate gyrus of the HPC birth-dated with BrdU co-expressing a neuronal marker. Mice treated with a range of doses of PSOP acquired a robust conditioned fear response. Mice injected with low doses of PSOP extinguished cued fear conditioning significantly more rapidly than high-dose PSOP or saline-treated mice. Injection of PSOP, 25I-NBMeO or ketanserin resulted in significant dose-dependent decreases in number of newborn neurons in hippocampus. At the low doses of PSOP that enhanced extinction, neurogenesis was not decreased, but rather tended toward an increase. Extinction of "fear conditioning" may be mediated by actions of the d…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This may explain why they have demonstrated efficacy in many preclinical rodent behavioral tests involving PFC circuitry including the forced swim test and fear extinction learning (151, 194–197).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [196]
In the citing paper
“At a biological level, psilocybin induced a dose-dependent effect on neurogenesis, with a low dose increasing, and a high dose decreasing neurogenesis (62).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [62]
In the citing paper
“Psilocybin-treated mice exhibited increased extinction compared to saline-treated controls for all doses, indicating a quicker learning response to fear (62).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [62]
In the citing paper
“Mice (n = 6) that were administered a single, low dose of psilocybin (0.1 mg/kg, i.p) showed a non-significant increase in proliferation of hippocampal progenitor cells 14 days later.”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [62]
In the citing paper
“Behavioral effects of psilocybin demonstrated a dose-independent stimulation of fear extinction”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [62]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
van Praag, H., Kempermann, G., & Gage, F. H. (1999) · Nature Neuroscience · doi:10.1038/6368 · Cited by 3,880
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592 · cited 1×
“Neurogenesis occurs throughout the life span in the adult brain, the subventricular zone (SVZ) and the subgranular zone (SGZ) in the DG (Altman 1962, 1969; Altman and Das 1965).”
BackgroundA review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
Modality-Specific Retrograde Amnesia of Fear
Kim, J. J., & Fanselow, M. S. (1992) · Science · doi:10.1126/science.1585183 · Cited by 2,483
Learning enhances adult neurogenesis in the hippocampal formation
Gould, E., Beylin, A., Tanapat, P., Reeves, A., & Shors, T. J. (1999) · Nature Neuroscience · doi:10.1038/6365 · Cited by 2,157 · cited 1×
“Evidence suggests that performance on HPC-dependent learning tasks is influenced by neurogenesis in the DG of the HPC (Van et al. 2002; Gould et al. 1999a, b; Nilsson et al. 1999; Shors et al. 2001, 2002).”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“Chronic administration of 5-HT agonists (including SSRIs) upregulates BDNF mRNA expression in the HPC (Nibuya et al. 1995, 1996).”
BackgroundNeurogenesis in the adult is involved in the formation of trace memories
Shors, T. J., Miesegaes, G., Beylin, A., Zhao, M., Rydel, T., & Gould, E. (2001) · Nature · doi:10.1038/35066584 · Cited by 2,023
The Emotional Brain, Fear, and the Amygdala
LeDoux, J. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025048802629 · Cited by 1,818 · cited 1×
“the dentate gyrus (DG), hilus, cornu ammonis (CA) 1 and CA3 and are colocalized on GABAergic neurons, pyramidal and granular cells (Luttgen et al. 2004; Morilak et al. 1993, 1994; Pompeiano et al. 1994; Shen and Andrade 1998; Cornea-Hebert et al. 1999).”
Background
Cited by
Items 201–279 of 279
Pohořalá, V., Kuchař, M., Spanagel, R., & Bernardi, R. E. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.09.006 · Cited by 8
Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration
Tal, T. B., Pogodin, I., Botvinnik, A., Lifschytz, T., Heresco‐Levy, U., & Lerer, B. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03428-x · Cited by 4
“Psilocin, the active metabolite of psilocybin, has been reported to induce changes in neuroplasticity, including neurogenesis, that were accompanied by extinction of conditioned fear-related behaviors [6, 23, 24].”
Dancing the Wild Divine: Drums, Drugs, and Individuation
Moores, D. J. (2020) · Journal of Jungian Scholarly Studies · doi:10.29173/jjs126s · Cited by 5
Psychedelics for Alzheimer's Disease Palliative Care
McManus, K. R., Patrick, R. E., Striepe, M. I., Drury, M. J., Ozonsi, R., Forester, B. P., & Weinberg, M. S. (2022) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2022.06.001 · Cited by 5
Uthaug, M. V. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200624mu · Cited by 5
Consciousness as a domain of extraterritoriality
Falcon, J. (2021) · Culture, theory and critique/Culture, theory & critique · doi:10.1080/14735784.2021.1908904 · Cited by 3
Davidson, M., Stanciu, G. D., Rabinowitz, J., Untu, I., Dobrin, R., & Tamba, B.-I. (2025) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2025.2480566 · Cited by 4
“…glutamatergic pathways, psilocybin has demonstrated anxi-olytic and antidepressant properties, especially in patients with major depression (catlow et al. 2013; carhart-Harris and Goodwin 2017). these same serotonergic mechanisms may help reduce neuropsychiatric symptoms commonly seen in…”
Learning as the unifying mechanism of psychedelic action
Caulfield, A., Young, A. H., & Mehta, M. A. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251405683 · Cited by 4
“…to test the effect of psychedelics on fear extinction, broadly showing enhanced fear extinction when psychedelics were administered before the extinction phase of the paradigm (Catlow et al., 2013; de la Fuente Revenga et al., 2021; Kelly et al., 2024; Werle et al., 2024; Woodburn et al., 2024).”
Zhang, J., Lin, C., Lv, X., Zhao, H., & Wang, X. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.02.011 · Cited by 5
Steinberg, M. I., Rosenberg, P., & Garcia‐Romeu, A. (2023) · Current Geriatrics Reports · doi:10.1007/s13670-023-00395-3 · Cited by 3
Gattuso, J. J., Bezcioglu, B., Wilson, C., Havaux, K., Hannan, A. J., & Renoir, T. (2025) · Psychedelics. · doi:10.61373/pp025i.0044 · Cited by 3
Seeing Neurodegeneration in a New Light Using Genetically Encoded Fluorescent Biosensors and iPSCs
Stellon, D., Talbot, J., Hewitt, A. W., King, A. E., & Cook, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021766 · Cited by 4
Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives
Yasin, B., Mehta, S. M., Tewfik, G., & Bekker, A. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00058 · Cited by 4
Psychedelic drugs as a long-needed innovation in psychiatryPreprint
Oña, G., & Bouso, J. C. (2020) · Qeios · doi:10.32388/t3em5e.2 · Cited by 3
“T he activation of 5-HT 2A receptors has been associated with neurogenesis [49,50], and neuronal plasticity [51].”
BackgroundAzadian, M. M., & George, P. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00040-1 · Cited by 3
White, A. M., Bauer, A. D., Faumont, S., & Lockery, S. R. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329538 · Cited by 2
Moshfeghinia, R., Mostafavi, S., Jazi, K., Ghasemi, A. R., Khosravani-Nezhad, Y., Narayanan, S., Ahmadi, J., & Pasalar, M. (2026) · BMC Psychology · doi:10.1186/s40359-025-03935-y · Cited by 4
Boehnke, K. F., Pouyan, N., & Aday, J. S. (2026) · Drugs · doi:10.1007/s40265-026-02339-5 · Cited by 2
“Accordingly, in preclinical studies, psilocybin has been shown to promote anti-inflammatory cytokines [27] and neuroplastic changes, including neurogenesis and synaptogenesis [28, 29].”
The influence of psilocybin on subconscious and conscious emotional learning
Casanova, A. F., Ort, A., Smallridge, J. W., Preller, K. H., Seifritz, E., & Vollenweider, F. X. (2024) · iScience · doi:10.1016/j.isci.2024.110034 · Cited by 4
Martire, G., Sipple, D., Baron, D. A., Gold, M. S., Lewandowski, K.-U., Dennen, C. A., Sharafshah, A., Elman, I., Thanos, P. K., Modestino, E. J., et al. (2024) · PubMed · Cited by 2
Psychedelics - A Cure for Sexual Trauma or a Risk Factor in Recreational and Treatment Settings?
Struble, C. A. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00372-x · Cited by 2
McGovern, H. T., Wellman, N., Hutchinson, B. T., Oestreich, L., Cooper, S., Fonzo, G. A., & Doss, M. K. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07163-z · Cited by 2
Langlitz, N. (2017) · Dialectical Anthropology · doi:10.1007/s10624-017-9452-y · Cited by 2
“Let us start with patience and impatience: after 14 years ofpainstaking labor, its author could not wait for his readers to engage and wrote a response to a kind and generous book review not yet written that got everything wrong about his book-"like aU book reviews, always" (Rees 2016b). Rees makes clear that he does…”
BackgroundNieto-Quero, A., Infantes-López, M. I., Zambrana-Infantes, E. N., Chaves-Peña, P., Gavito, A., Munoz-Martin, J., Tabbai, S., Márquez, J., de Fonseca, F. R., Garcia‐Fernandez, M. I., et al. (2023) · Cells · doi:10.3390/cells12182290 · Cited by 1
“In fact, proteins are essential for cellular adaptation to environmental signals and cellular aspects of disease development [15,16].”
BackgroundLange, B., Morgan, L., Mattox, C., Pathak, S., Liu, K., Nadar, R. M., ren, J., Jeyabalan, J. B., Moore, T., & Dhanasekaran, M. (2024) · Trends in Medical Research · doi:10.3923/tmr.2024.245.273 · Cited by 1
“These receptors bind serotonin (serotonergic) and have seven different subtypes, each with further groupings beneath them 23 .”
Usage of Psilocybin to Treat Huntington's Disease: A Research Protocol
Duan, C., Farkhondehpay, N., Safa, V., & Yuan, E. (2024) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.644 · Cited by 1
“…as the same study by Jefsen and colleagues found much less genetic regulation of the same genes in the hippocampus compared to the cortex, and another study by Catlow et al. found that low doses (0.1 mg/kg) may increase neurogenesis, but higher doses (1mg/kg) significantly decrease it [30].”
ResultInfluentialEl‐Mansoury, B., Haj-Khlifa, A., Laadraoui, J., Fatimi, H. E., Dalil, E. M., Hammani, M., Hiba, O. E., Boulbaroud, S., Bitar, A., & Jayakumar, A. R. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-2089-1.ch003 · Cited by 2
Chronic α5‐ GABA ‐A Receptor Potentiation Promotes Mouse Adult Hippocampal Neurogenesis
Prévot, T. D., Marcotte, M. D., David, D. J. P., Mendez‐David, I., Mian, M. Y., Cook, J. M., Guilloux, J., & Sibille, E. L. (2025) · Hippocampus · doi:10.1002/hipo.70019 · Cited by 1
“…of action, such as metformin (J. Wang et al. 2012), trametinib (a kinase inhibitor for cancer) (Kim et al. 2023) and psychedelics like psilocybin (Catlow et al. 2013; Lino de Oliveira et al. 2020; Malberg 2004) increase AHN in the adult brain, little is known about GABAergic drugs contribution…”
The Solution to Overpopulation, The Depletion of Resources and Global Warming
Diamand, M. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000140 · Cited by 1
Alam, Z., & Soma, B. (2023) · The Meducator · doi:10.35493/medu.43.18 · Cited by 1
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1
Johnson, K. (2016) · Defense Technical Information Center (DTIC) · doi:10.21236/ad1009505 · Cited by 2
Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen
Rougemont-Bücking, A. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_62
Literature review: Considerations for Psychedelic Research
Hawkins, C. (2013) · UC Merced Undergraduate Research Journal · doi:10.5070/m451020759
If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice
Klein, L. M. (2018) · eScholarship (California Digital Library)
Clarifying the mechanisms by which psychedelics achieve therapeutic efficacy
Jones, A. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0371155
Use of MDMA & Psilocybin in the Treatment of PTSD
Grant-Howard, C., & Steele, J. S. (2019) · PDXScholar (Portland State University)
Proceedings 榊原カンファレンス 今回の症例 : 心房細動 : 薬物療法の経過からカテーテルアブレーション実施に至るまで
梅村, 純. (2012) · CORE journal循環器 : current opinion & review for the next stage
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm · Cited by 1
Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen
Rougemont-Bücking, A. (2016) · Springer eBooks · doi:10.1007/978-3-642-55214-4_62-1
Die Rolle von psychoaktiven Substanzen bei Lern- und Anpassungsprozessen
Rougemont-Bücking, A. (2020) · Springer Reference Psychologie · doi:10.1007/978-3-642-55214-4_62-2
Faculty Opinions recommendation of Psychedelics promote structural and functional neural plasticity.
Chapman, E. R., & Vevea, J. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733441066.793547403
Harjai, N. (2022) · Advances in Clinical Medical Research and Healthcare Delivery · doi:10.53785/2769-2779.1108
“It is thought that chronic stress leads to excessive glutamate release which contributes to neuronal atrophy/connectivity and decreased hippocampal neurogenesis.(16) We have seen that antidepressants can reverse this to some extent.”
Hutten, N. R. P. W. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220630nh
Death risk: Lack of movement: The ignored pandemic of digitalization escalates the COVID-19 crisis
Pawlik, L. (2021) · Technoetic Arts · doi:10.1386/tear_00058_1
JSE 36:4 Winter 2022 Full Issue
Laythe, B. R. (2023) · Journal of Scientific Exploration · doi:10.31275/20222881
Mycotherapeutics Affecting Dopaminergic Neurotransmission to Exert Neuroprotection
Kim, S., Nadar, R. M., DeRuiter, J., Pathak, S., Ramesh, S., Moore, T., Agrawal, D. C., & Dhanasekaran, M. (2023) · Springer eBooks · doi:10.1007/978-981-19-9550-7_13
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Unveiling the Neuroscientific Underpinnings of Mood and Anxiety Disorders
Institut Pasteur, U. P. C., & Lledo, P. (2023) · Annals of Depression and Anxiety · doi:10.26420/anndepressanxiety.2023.1120
SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18496-3.00015-x
Foldi, C. J., Liknaitzky, P., Williams, M. L., & Oldfield, B. J. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.24022012
Psilocybin and other Psychedelics
Kaye, A. P., Kelmendi, B., Rivera, M. N., & Pittenger, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00178-0
Chapter 51. Treatment of Posttraumatic Stress Disorder
Nemeroff, C. B., Rosen, V., & Ortiz, N. F. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as51
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141 · Cited by 1
Microdosing Psychedelics for Cognitive Enhancement: A Naturalistic Exploration of User Experiences
Pelham, L. (2025) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/tvwc-80bg
Mechanisms of neuroplasticity induced by permeable serotonergicsPreprint
Fedorov, A. (2025) · doi:10.58445/rars.3131
Psilosybiinin vaikutus neuroplastisiteettiin
Anttonen, P., & Ylönen, E. (2024) · UTUPub (University of Turku)
Taugungamyndun í fullorðnum spendýrum: Fræðilegt yfirlit
Sigurþórsson, J. T., & Sigurðsson, B. K. (2023) · Skemman
Yonus, R. (2023) · DiVA (Linkoping University) · Cited by 1
Dilmaç, E. (2023) · Lund University Publications Student Papers (Lund University)
Medicinal Mushrooms and Mental Disorders: How Mushrooms Affect Anxiety and Depression
Tarki, A., Hajikarim‐Hamedani, A., Rassa, S., & Khosravi, S. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2774-8_6
Diehl, V. J., Calder, A. E., & Hasler, G. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251397306 · Cited by 1
“…memory reconsolidation, potentially enabling the attenuation of traumatic memories into less distressing perceptions (Cameron et al., 2018, 2019; Catlow et al., 2013; Curry et al., 2018; Du et al., 2023; Kelly et al., 2024; Werle et al., 2024; Young et al., 2015, 2017) and initial clinical…”
Inserra, A., Murray, C. J., Campanale, A., VanderZwaag, J., & Tremblay, M. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1690318 · Cited by 1
The Effects of Psychedelic-Assisted Therapy on Illness and Death Anxiety
Amaev, A. (2024) · TSpace (University of Toronto)
Psilocybin and Ibogaine in Cocaine‐Seeking: Extinction Enhancement Without Relapse Prevention
Koutrouli, I. R. A., Brejtr, V., Schwendt, M., Witek, K., Charalambous, C., Aleksič, K., Miniariková, N., Lhotková, E., Toman, M., Nikolič, M., et al. (2026) · Addiction Biology · doi:10.1111/adb.70111 · Cited by 1
Athéa, H. (2024) · theses.fr (ABES) · doi:10.70675/d1402550z7fe9z4237z90d2z4845d24c1bde · Cited by 1
Wilde, A. (2026) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Carhart-Harris, R. L., Zeifman, R. J., Pasquini, L., Nandi, B., Rohani-Shukla, C., Suseelan, S., Mediano, P. A. M., Rosas, F. E., Timmermann, C., Kettner, H., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1875339 · Cited by 1
“…phenotypes, then markers and mechanisms of extinction learning (Bouton, 2004) or “unlearning” may be more relevant and conducive to PP (Du et al., 2023; Sottile and Vida, 2022; Catlow et al., 2013; Schindler et al., 1986) than the classical markers and mechanisms of Hebbian learning, such as LTP.”
Du, Y. J., Zhao, X., Yao, Y., Li, Y., Wang, G., & Zhang, L. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261453819
Olejníková, L., Kútna, V., Mazochová, K., Šíchová, K., Danda, H., Lhotková, E., Uttl, L., Brejtr, V., Syrová, K., Mazoch, V., et al. (2026) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2026.174231
Proliferative Effects of the Psychedelic N,N -Dimethyltryptamine (DMT) in Human Neural Stem Cells
Salerno, J. A., Dominguez, E. R., Karmirian, K., Arrais, B. A. B. M. S., Alves, J., Erjautz, G., Kroening, K., Souza, L. R. Q., Ornelas, I. M., & Rehen, S. K. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00209
Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
Kaup, K., Jiménez, J. H., & Aru, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106876 · Cited by 3
MDMA-Enhanced Exposure Therapy Reverses PTSD-Like Features In a Learned Helplessness Mouse ModelPreprint
Shahar, O., Golding, P., Chaykin, M., Ari, M. B., Botvinnik, A., Lifschytz, T., & Lerer, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743271
Psilocibina e neuroplasticidade: novas perspectivas terapêuticas para depressão resistente
Castro, L. A., Júnior, A. L. A. S., Simões, G. G. C., de Souza, V. R. S., Pereira, L. L. M. D., Lacerda, A. L. D. S., & da Silva, C. L. (2026) · Vértices · doi:10.19180/1809-2667.v28n22026.23658
Du, Y., Zhao, X., Chen, Q., Bai, Y., Zhang, Y., Chen, R., & Wang, G. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004350
Hogg, D. E., Romanos, J., Albiez, J., Hofer, C., Wicki, S., Argunşah, A. Ö., Sigrist, H., Thomann, J., Luethi, D., Vollenweider, F. X., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1918182
“There are several reports of reduced freezing when PSY is administered shortly – 5–30 min–before memory testing (e.g., (Catlow et al., 2013; Hagsäter et al., 2021; Du et al., 2023; Kelly et al., 2024; Woodburn et al., 2024).”
InfluentialPsilocybin enhances conditioned place preference learning in planarians
Ellenbroek, B. A., Naylor, B., & Youn, J. (2026) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000903
Zhai, H., Wang, H., Wang, Y., & Wang, X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03939-z
Metadata
- Authors
- Catlow, B. J., Song, S., Paredes, D. A., Kirstein, C. L., & Sanchez-Ramos, J.
- Affiliations
- Lieber Institute for Brain Development (US)
- University of South Florida (US)
- Venue
- Experimental Brain Research
- Published
- 2013-06-02
- Volume
- 228
- Issue
- 4
- Pages
- 481-491
- ISSN
- 0014-4819 (ISSN-L)
- 1432-1106
- OpenAlex
- W2051271111
- Semantic Scholar
- f85018b1b5d6ec225219bde72260340ba25be97a
- Cited by
- 266
- References
- 70
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 45 · 2023: 40 · 2022: 30 · 2021: 29 · 2020: 28 · 2019: 12 · 2018: 11 · 2017: 7 · 2016: 16 · 2015: 4 · 2014: 6 · 2013: 1
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Experimental Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- psilocybin, hippocampal neurogenesis, trace fear conditioning, fear extinction, 5-HT2A receptor agonists, ketanserin, serotonin, dentate gyrus, BrdU labeling, post-traumatic stress disorder, amygdala
- MeSH terms
- Animals, Conditioning, Psychological, Extinction, Psychological, Fear, Hallucinogens, Hippocampus, Male, Mice, Inbred C57BL, Psilocybin, Mice, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.